Literature DB >> 16114133

Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry.

Mayuko Takagawa1, Naoki Muguruma, Kaori Oguri, Yoshitaka Imoto, Koichi Okamoto, Kunio Ii, Susumu Ito.   

Abstract

Mucin core proteins are known to be present in various organs and are specifically expressed with carcinogenesis and closely associated with the prognoses of various malignant tumors in the digestive tract such as colorectal cancer. The present study evaluated correlations between mucin and p53 expression and prognosis of gallbladder cancer using surgically resected tissue specimens from 26 patients with gallbladder carcinoma surgically treated at our hospital. Immunohistochemical staining was performed using MUC 1, MUC2, and p53 monoclonal antibody. The level of antigen expression in the lesion was classified into four stages: none(-), slight(+), moderate (++), and severe (+ + +). According to the UICC classification, histopathological grading, levels of T, N, and M factors, and tumor stages were compared with regard to the correlations with mucin and p53 expression. All cases were classified into two groups according to the results of mucin immunohistochemistry: group A (MUC1, > or = ++; and MUC2, < or = +) and group B (MUC1, < ++; or MUC2, > +). Postoperative survival periods were compared between the two groups and p53-positive and -negative groups. Neither histological grading nor T factor correlated with mucin or p53 expression, respectively. Moreover, neither N factor nor M factor correlated with mucin or p53 expression. Furthermore, stage grouping did not correlate with mucin or p53 expression. However, when the correlation between the postoperative survival period and mucin expression was evaluated, the mean postoperative surgical period was significantly shorter in Group A than in Group B (1.02 years in Group A vs 2.92 years in Group B; P = 0.016). There was no relationship between postoperative survival period and p53 positivity. Mucin expression was independent of various tumor growth factors and clearly reflected the prognosis of gallbladder cancer. Because the relative malignancy of gallbladder cancer could be evaluated by examining the level of glycoprotein expression in tumor tissue, mucin could be a more important marker than p53 for predicting prognosis in gallbladder carcinoma using surgically resected tissue specimens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16114133     DOI: 10.1007/s10620-005-2854-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder.

Authors:  M Sasaki; T Yamato; Y Nakanuma; S B Ho; Y S Kim
Journal:  Pathol Int       Date:  1999-01       Impact factor: 2.534

2.  Expression of MUC1 and MUC2 mucin core proteins and their messenger RNA in gall bladder carcinoma: an immunohistochemical and in situ hybridization study.

Authors:  T Yamato; M Sasaki; Y Watanabe; Y Nakanuma
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

3.  Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.

Authors:  M Higashi; S Yonezawa; J J Ho; S Tanaka; T Irimura; Y S Kim; E Sato
Journal:  Hepatology       Date:  1999-12       Impact factor: 17.425

4.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.

Authors:  H Kashiwagi; H Kijima; S Dowaki; Y Ohtani; K Tobita; M Tsukui; Y Tanaka; H Matsubayasi; T Tsuchida; H Yamazaki; M Nakamura; Y Ueyama; M Tanaka; T Tajima; H Makuuchi
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

Review 5.  Expression of mucin antigens in human cancers and its relationship with malignancy potential.

Authors:  S Yonezawa; E Sato
Journal:  Pathol Int       Date:  1997-12       Impact factor: 2.534

6.  Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene, and p53 oncosuppressor gene.

Authors:  E Sasatomi; O Tokunaga; K Miyazaki
Journal:  Cancer       Date:  1996-11-15       Impact factor: 6.860

7.  Increased expression of MUC1 in advanced pancreatic cancer.

Authors:  Yuji Hinoda; Yoshito Ikematsu; Michiko Horinochi; Shuji Sato; Kotaro Yamamoto; Tomoko Nakano; Mikiko Fukui; Yutaka Suehiro; Yuichiro Hamanaka; Yoshiro Nishikawa; Hideo Kida; Shinji Waki; Masaaki Oka; Kohzoh Imai; Suguru Yonezawa
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

8.  p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival.

Authors:  I Diamantis; E Karamitopoulou; E Perentes; A Zimmermann
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

9.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

10.  p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.

Authors:  I I Wistuba; A F Gazdar; I Roa; J Albores-Saavedra
Journal:  Hum Pathol       Date:  1996-04       Impact factor: 3.466

View more
  6 in total

1.  Expression of cell cycle-related proteins, p16, p53 and p63 as important prognostic markers in gallbladder adenocarcinoma.

Authors:  Kyungeun Kim; Dong-Hoon Kim; Seoung Wan Chae; Jun-Ho Shin; Hong Joo Kim; Sung-Im Do; Hyun Joo Lee; Ji Hae Koo; Jung-Soo Pyo; Jin Hee Sohn
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

2.  Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.

Authors:  Troels Zakarias Kristiansen; H C Harsha; Mads Grønborg; Anirban Maitra; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2008-10-08       Impact factor: 4.466

3.  miR-125b suppresses cellular proliferation by targeting c-FLIP in gallbladder carcinoma.

Authors:  Huajie Zong; Huading Zhou; Yang Xiang; Gang Wu
Journal:  Oncol Lett       Date:  2019-10-18       Impact factor: 2.967

4.  Molecular biology of gallbladder cancer: potential clinical implications.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2012-10

5.  Prognostic significance of muc4 expression in gallbladder carcinoma.

Authors:  Hyeon Kook Lee; Min-Sun Cho; Tae Hun Kim
Journal:  World J Surg Oncol       Date:  2012-10-27       Impact factor: 2.754

Review 6.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.